NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| GSK | GlaxoSmithKline PLC | Healthcare | Drug Manufacturers - General | 5.90% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 5.48% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 5.07% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.78% |
| 6160 | Beigene Ltd | Healthcare | Biotechnology | 4.77% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.39% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 4.35% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.29% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.25% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| GMAB | Genmab A/S | Healthcare | Biotechnology | 4.14% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.11% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.10% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 4.04% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.93% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 3.82% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.53% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 3.46% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 3.09% |